| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $176.1M | -12.4% |
| SG&A Expense | $60.1M | -3.9% |
| Operating Income | -$241.2M | +8.5% |
| Interest Expense | $2.0M | — |
| Pre-tax Income | -$236.8M | +2.8% |
| Income Tax | $130K | -27.0% |
| Net Income | -$236.9M | +2.8% |
| EPS (Basic) | -$1.45 | +5.2% |
| EPS (Diluted) | -$1.45 | +5.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $182.5M | +28.4% |
| Short-term Investments | $165.4M | +0.0% |
| Current Assets | $190.5M | -39.3% |
| Total Assets | $191.0M | -39.7% |
| Current Liabilities | $32.5M | +8.6% |
| Long-term Debt | $54.5M | — |
| Total Liabilities | $87.2M | +191.5% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$206.4M | -12.8% |
| Investing Cash Flow | $168.5M | +338.8% |
| Financing Cash Flow | $77.1M | +256.8% |
| $103.9M |
| -63.8% |